Product Images Cimzia
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 21 images provide visual information about the product associated with Cimzia NDC 50474-710 by Ucb, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure - cimzia 01
This appears to be a chart showing the percentage of patients in a study sorted by different weeks and treatment groups. The study includes a placebo plus MTX group with 199 patients and a group of 393 patients receiving CIMZIA 200 mg plus MTX. However, without further information, it is difficult to provide a more detailed description.*
Figure 2 - cimzia 02
This is a table of data showing the response rates to different dosages of a medication called CZP in a group of participants over a span of 24 weeks. The table consists of three groups, with two of them receiving either 200mg CZP every 2 weeks, or 400mg CZP every 4 weeks respectively, while the third group, indicated as the control, received a placebo. The numbers in each group are 136, 138, and 135 respectively, with the response rates indicated in percentages along the Y-axis. The X-axis shows the duration of the study in weeks.*
Figure 3 - cimzia 02a
The provided text is a comparison table of three different treatments, namely Placebo, CIMZIA 200mg Q2W and CIMZIA 400mg Q4W, administered to a population of 57, 65 and 56 patients respectively. However, the statement "The same patients may not have responded at each time point" indicates that the table is likely part of a larger study analyzing treatment response over time, but without additional information or context, it is difficult to provide a more specific description.*
cimzia 02b
Figure A and B - cimzia 03
Figure C - cimzia 04
Figure D - cimzia 05
Figure E - cimzia 06
Figure F - cimzia 07
Figure G - cimzia 08
Figure H - cimzia 09
Figure I - cimzia 10
Figure J - cimzia 11
Figure 1 - cimzia 12
Figure 2 - cimzia 13
Figure 3 - cimzia 14
Figure 4 - cimzia 15
Figure 5 - cimzia 16
Figure 6 - cimzia 17
Principal Display Panel - 200 mg/vial carton - cimzia 18
This is a description of a medication with the NDC code 50474-700-62, called Cimziqa. The medication is for subcutaneous use only and contains 200mg/vial of Certolizumab pegol. The contents of the carton must not be separated prior to use. The medication must be reconstituted for 5 seconds. There are 2 injection kits each containing 200mg. The text includes contact information to enroll patients in the Ollicly Nursing program by calling 1-844-UCh Norso (1-844-622-6677). The rest of the text appears to be formatting, disclaimers, and legal information and does not provide any useful information.*
PRINCIPAL DISPLAY PANEL - 200 mg/mL Syringe Carton Box - cimzia 19
This text is a description of the Cimzia starter kit (certolizumab pegol) for subcutaneous injection. It contains 3 cartons of 2 prefilled syringes each, with a concentration of 200 mg/mL. The entire carton should be dispensed as one unit, and a medication guide should be given to each patient. The text also includes a phone number for patient support.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.